SBC Medical Group Holdings Inc., a leading global franchise and provider of services for aesthetic clinics, has achieved a significant milestone by being added to the Russell 3000® Index, a move that underscores its growing influence in the market. This inclusion, effective as of June 30, 2025, not only enhances the company’s visibility among a broader base of investors but also serves as a testament to its relevance in the evolving U.S. economy. The Russell indexes, widely utilized by investment managers and institutional investors, benchmark approximately $18.1 trillion in assets globally, with $10.6 trillion in the U.S. alone, highlighting the importance of SBC Medical Group’s new status.

The company’s shares experienced a positive response on the first day of trading following its inclusion in the Russell 2000, a common trend for newly added companies. This development is expected to reduce stock volatility and attract more institutional investors, further validating SBC Medical Group’s market significance. Fiona Bassett, CEO of FTSE Russell, emphasized the importance of the Russell indexes’ adaptability to the dynamic U.S. economy, ensuring accurate market representation.

In addition to its index inclusion, SBC Medical Group has announced the appointment of Shinya Inoue as its new Chief Marketing Officer. Inoue, with his extensive experience in brand strategy and digital marketing, is poised to enhance the company’s brands, including Shonan Beauty Clinic, one of Japan’s largest aesthetic medical brands. His leadership is anticipated to drive the company’s global expansion and elevate its brand value, leveraging digital innovation to meet the growing demand for cosmetic surgery services worldwide.

The cosmetic surgery market’s expansion, particularly in Japan and globally, is reflected in SBC Medical Group’s robust performance. The company reported a 5% year-over-year increase in earnings per share to $0.21 and a rise in EBITDA margins to 52% for the first quarter of 2025. With 251 clinics and a high customer retention rate, SBC Medical Group is well-positioned for continued growth. The strategic moves of joining the Russell 3000 Index and appointing a new CMO underscore the company’s commitment to expanding its footprint in the aesthetic medical industry, making it a notable player to watch in the coming years.

This news story relied on content distributed by None. Blockchain Registration, Verification & Enhancement provided by NewsRamp. The source URL for this press release is SBC Medical Group Joins Russell 3000 Index and Appoints New CMO Amid Global Expansion.